Uveitis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Uveitis Treatment Market is segmented By Treatment (Corticosteroids, Antibiotics, Antivirals, Antifungal, Analgesics, and Others), By Disease (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, and Panuveitis), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America).

Uveitis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Uveitis Treatment Market Size

Uveitis Treatment Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 5.80 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Uveitis Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Uveitis Treatment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Uveitis Treatment Market Analysis

The Global Uveitis Treatment Market is expected to register a CAGR of 5.8% during the forecast period.

The market for uveitis treatment is expected to be affected by the COVID - 19 outbreak which is majorly attributed to the lockdown being followed by major countries. Disrupted the supply chain had a direct impact on the market studied as many drugs could not reach the market on time. Uveitis patients are potentially at higher risk of exposure to infections including COVID-19. These above-mentioned elements are expected to burden the revenue trajectory of the global Uveitis Treatment market over the forecast period. However, as respective governing authorities have lifted these enforced lockdowns, the global Uveitis Treatment market is expected to recover accordingly.

The increasing prevalence of optical infections and chronic eye disorders across the globe represents is one of the key factors driving the growth of the market. Uveitis is highly prevalent among individuals suffering from diabetes, eye injuries, cataract, glaucoma, cystoid macular edema, band keratopathy, and autoimmune and inflammatory disorders. Furthermore, the market is being driven by the growing senior population, which is more sensitive to such disorders. If measures are not taken properly, these diseases can easily spread through human touch (through hands, clothes, or bedding) and by flies that have to meet discharges from an infected person's eyes or nose. In September 2021, a Non-profit group, Prevent Blindness, conducted awareness campaign on various forms of Inflammatory Eye Diseases (IED). In October 2021, ABIONYX Pharma announced the positive pre-clinical results for ER-001 in uveitis treatment and the development of first-class of biomedicines from its bio-HDL for the treatment of ocular pathologies. Thus, the government initiatives for the management of eye pathologies and rising R&D activities for the development of new therapies are some of the significant factors expected to drive the market growth.

Moreover, Trachoma is a disease of the eye caused by infection with the bacterium Chlamydia trachomatis. In March 2020, according to data published by World Health Organization (WHO), around 137 million people live in trachoma endemic areas and are at risk of trachoma blindness. Therefore, the high and increasing prevalence rate of these infectious diseases resulted in the increasing awareness regarding the available alternative treatments for managing uveitis are anticipated to drive the market further. Moreover, various technological advancements in the treatment alternatives, such as the development of non-steroidal injectables and anti-tumor necrosis factor (TNF) drugs, are acting as other growth-inducing factors.

Uveitis Treatment Industry Overview

The uveitis treatment market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are AbbVie (Allergan), Inc., and Novartis AG, Bausch Health Inc., AbbVie Inc., Eyegate Pharmaceuticals, Inc., Alimera Science Inc., EyePoint Pharmaceuticals, Santen Pharmaceuticals, and others.

Uveitis Treatment Market Leaders

  1. Bausch Health Inc.

  2. AbbVie Inc.

  3. Eyegate Pharmaceuticals, Inc.

  4. Clearside Biomedical inc.

  5. EyePoint Pharmaceuticals

  6. *Disclaimer: Major Players sorted in no particular order
Uveitis Treatment Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Uveitis Treatment Market News

  • In October 2021, Bausch + Lomb and Clearside Biomedical announced that the United States Food and Drug Administration (FDA) has approved XIPERE (triamcinolone acetonide). XIPERE is an injectable suspension administered through a suprachoroidal route to treat macular edema associated with uveitis.
  • In December 2020, Alimera Sciences Europe Limited has launched ILUVIEN in the Netherlands. ILUVIEN is used in the treatment of diabetic macular edema (DME) and non-infectious uveitis affecting the posterior segment (NIPU). The strategy behind the launch is geographic expansion, making ILUVIEN available for more physicians and patients in new markets.

Uveitis Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Uveitis and its Complications
    • 4.2.2 Rising Expenditure on the Research and Development of New Drugs and Treatments
  • 4.3 Market Restraints
    • 4.3.1 Steep Prices of Medications and Side Effects of The Medication
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Treatment
    • 5.1.1 Corticosteroids
    • 5.1.2 Antibiotics
    • 5.1.3 Antivirals
    • 5.1.4 Antifungal
    • 5.1.5 Analgesics
    • 5.1.6 Others
  • 5.2 By Disease
    • 5.2.1 Anterior Uveitis
    • 5.2.2 Posterior Uveitis
    • 5.2.3 Intermediate Uveitis
    • 5.2.4 Panuveitis
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Novartis AG
    • 6.1.2 Bausch Health Inc.
    • 6.1.3 AbbVie Inc.
    • 6.1.4 Eyegate Pharmaceuticals, Inc.
    • 6.1.5 Alimera Science Inc.
    • 6.1.6 EyePoint Pharmaceuticals
    • 6.1.7 Santen Pharmaceuticals
    • 6.1.8 Clearside Biomedical inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Uveitis Treatment Industry Segmentation

As per the scope of this report uveitis treatment refers to various remedies for treating inflammation in the uvea and surrounding tissues. The disease is characterized by blurred vision, dark or floating spots in the vision, redness of the eye, and sensitivity to light. The Uveitis Treatment Market is segmented By Treatment (Corticosteroids, Antibiotics, Antivirals, Antifungal, Analgesics, and Others), By Disease (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, and Panuveitis), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD billion) for the above segments.

By Treatment Corticosteroids
Antibiotics
Antivirals
Antifungal
Analgesics
Others
By Disease Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Uveitis Treatment Market Research FAQs

What is the current Global Uveitis Treatment Market size?

The Global Uveitis Treatment Market is projected to register a CAGR of 5.8% during the forecast period (2025-2030)

Who are the key players in Global Uveitis Treatment Market?

Bausch Health Inc., AbbVie Inc., Eyegate Pharmaceuticals, Inc., Clearside Biomedical inc. and EyePoint Pharmaceuticals are the major companies operating in the Global Uveitis Treatment Market.

Which is the fastest growing region in Global Uveitis Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Uveitis Treatment Market?

In 2025, the North America accounts for the largest market share in Global Uveitis Treatment Market.

What years does this Global Uveitis Treatment Market cover?

The report covers the Global Uveitis Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Uveitis Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Uveitis Treatment Industry Report

Statistics for the 2025 Global Uveitis Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Uveitis Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Uveitis Treatment Market Report Snapshots